Sunway Healthcare shares rose 28% of their first day of buying and selling, following the corporate’s 2.9 billion ringgit ($732 million) IPO, the nation’s largest in practically a decade. Shares of the Kuala Lumpur-based hospital operator, beforehand the healthcare arm of Malaysian conglomerate Sunway Group, closed at 1.85 ringgit on Wednesday, up from the supply worth of 1.45 ringgit. The itemizing is Malaysia’s largest since 2017’s IPO of Lotte Chemical Titan Holdings.
Sunway Group beforehand mentioned the spin-off will assist unlock shareholder worth and enhance the enterprise’s entry to capital markets. In Sunway Healthcare’s IPO prospectus, Sunway described the well being enterprise as a “distinct and viable business of its own.”
Sunway Healthcare generated 1.6 billion ringgit ($403 million) in income throughout the first 9 months of 2025, a 17.8% year-on-year leap, based on its prospectus. But the corporate’s earnings over the identical interval declined by 22% year-on-year to hit 140 million ringgit ($35.4 million).
Sunway Group, No. 190 on Fortune’s Southeast Asia 500 record, posted file income of 9.8 billion ringgit ($2.5 billion) in 2025, up 24.5% from the yr earlier than. The income leap was fueled by sturdy efficiency throughout most of its enterprise segments, together with property funding and development.
Malaysia’s greying inhabitants
Sunway hopes to faucet rising healthcare demand in an getting older and wealthier Malaysia. “The outlook for Malaysia’s private healthcare services industry remains positive,” Sunway Group wrote in its This autumn 2025 earnings report. “Malaysia has one of the largest middle-income populations in ASEAN, coupled with rising life expectancy and a growing incidence of non-communicable diseases.”
Malaysia has a quickly getting older inhabitants, with 14.5% of its inhabitants set to be 65 and older by 2040, based on the Malaysian Division of Statistics. Over 2 million Malaysians live with non-communicable ailments together with diabetes, hypertension, excessive ldl cholesterol and weight problems.
Traders are wanting to spend money on Malaysia’s healthcare growth. KPJ Healthcare, No. 303 on Fortune’s Southeast Asia 500, hit a file share worth of three.53 ringgit throughout intraday buying and selling on March 18.
Malaysia’s inventory change, the Bursa Malaysia, has additionally been having a blockbuster yr. The KLCI Composite Index is up by 14.1% over the previous 12 months, and breached a six-year excessive in mid-January. In response to Deloitte, Malaysia had extra IPOs than different Southeast Asian markets, with 59 IPOs elevating 5.5 billion ringgit ($1.4 billion) in 2025.
The Malaysian ringgit has additionally risen to its strongest worth in 5 years, propelled by AI optimism and rising power costs. “The Ringgit should be one of the best performing currencies in Asia this year,” wrote Goldman Sachs strategists in a March 14 analysis word.
The Fortune 500 Innovation Discussion board will convene Fortune 500 executives, U.S. coverage officers, high founders, and thought leaders to assist outline what’s subsequent for the American economic system, Nov. 16-17 in Detroit. Apply right here.
